Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from Wellnex Life Ltd ( (AU:WNX) ) is now available.
Wellnex Life has disclosed that an Appendix 3Y notice was lodged late due to an administrative oversight during the Christmas–New Year period, while affirming that it understands its ASX disclosure obligations and has processes in place to ensure timely future filings. The company also detailed off-market internal share transfers within entities associated with Homart Group, involving a total of 1,285,409 Wellnex Life shares moved from Homart Group to JYSF Management Pty Ltd and MYLY Management Pty Ltd, and confirmed that Homart Group Pty Ltd and MYLY Management Pty Ltd now have independent boards and are no longer associated with director Jeffrey Yeh, meaning these entities will act independently regarding their Wellnex Life holdings and upcoming ASIC filings will formalise this change in association status.
The most recent analyst rating on (AU:WNX) stock is a Hold with a A$0.14 price target. To see the full list of analyst forecasts on Wellnex Life Ltd stock, see the AU:WNX Stock Forecast page.
More about Wellnex Life Ltd
Wellnex Life Limited (ASX/AIM: WNX) is an Australia- and UK-listed company operating in the health and wellness sector, focused on developing and marketing consumer health products. The company works with various strategic partners and investment entities that hold stakes in Wellnex Life, reflecting a shareholder base that includes corporate and trust structures associated with industry participants.
Average Trading Volume: 76,981
Technical Sentiment Signal: Sell
Current Market Cap: A$11.19M
Find detailed analytics on WNX stock on TipRanks’ Stock Analysis page.